Cedars Sinai

Los Angeles, California - The Cedars-Sinai Carcinoid and Neuroendocrine Tumor Program provides comprehensive multidisciplinary care for patients with carcinoid and neuroendocrine tumors. Their team has access to the most current techniques for diagnosis and treatment and is one of the few such programs in the United States.

The Carcinoid and Neuroendocrine Tumor Program provides comprehensive treatment for all types of neuroendocrine tumors. At Cedars-Sinai, we have access to the most sophisticated types of laparoscopic and minimally invasive surgery for primary tumors and liver metastases.

This program also has one of the largest and most comprehensive clinical research programs in the country devoted to these rare diseases, bringing leading-edge treatments to our patients.

Among the treatments under study are the new somatostatin analogs pasireotide and lanreotide, and multiple oral targeted biological agents that prevent cancer cells from multiplying without the toxicity of traditional chemotherapy. These include many types of m-TOR inhibitors, including everolimus and TORC-1+TORC-2 inhibitors, and peptide receptor radiotherapy PRRT. They also have clinical trials using immune stimulants and anti-angiogenic agents.

Cedars-Sinai is involved in numerous laboratory research studies related to neuroendocrine tumors. Some of these studies are funded by the National Institutes of Health (NIH). Researchers at the Carcinoid and Neuroendocrine Tumor Program are investigating the molecular genesis of carcinoid and neuroendocrine tumors, as well as innovative subcellular therapy.

For example, through translational research, they have discovered a novel disease involving pancreatic neuroendocrine tumors. An animal model of the tumor has been identified here and is used by our researchers to study pathogenesis and treatment. Other research conducted at Cedars-Sinai has helped identify genetic mechanisms involved in tumor growth and resistance to treatment.

Learn more about Cedars-Sinai Carcinoid and Neuroendocrine Tumor Program.

Learn more about the multidisciplinary team of medical professionals at the Cedars-Sinai Carcinoid and Neuroendocrine Tumor Program.